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Introduction
Evidence-Based Medicine (EBM) is a form of medicine 
aiming at transforming the delivery of healthcare based on 
a systematic and detailed approach that integrates patient’s 
values with clinical expertise and current best research evi-
dence.  According to the definition given by David Sackett, 
who is considered the founding father of EBM, “Evidence-
based medicine is the conscientious, explicit, and judicious use 
of current best evidence in making decisions about the care 
of individual patients.  The practice of evidence-based medi-
cine means integrating individual clinical expertise with the 
best available external clinical evidence from systematic re-
search”[1].  The concept of EBM was introduced in 1991 by 
Gordon Guyatt [2], even though many underlying principles 
have been developed earlier by the Scottish epidemiologist 
Archi Cochrane, who is also considered to be the originator 
of the idea of evidence-based medicine in our era [3, 4].  For 
his distinguished services towards EBM, Archi Cochrane 
has been honored through the naming of evidence-based 
medical research centers as Cochrane Centers and an inter-
national organization as the Cochrane Collaboration.  Many 
programs have been developed lately to make EBM more 
accessible to medical practitioners.  Among relevant EBM 
publications can be listed EBM reviews published by the Co-
chrane Center, the periodical Clinical Evidence launched by 
the BMJ Publishing Group, the Journal of Evidence-Based 
Medicine published by the Wiley Editing Services, etc. In 
many countries, EBM courses are also included in the stan-
dard curriculum of the medical schools.  Furthermore, now-
adays evidence-based practice is becoming a goal for health 
care institutions and often an accreditation requirement [5]. 
Evidence-Based Medicine – a six step approach
The practice of EBM provides a unique and enriching ex-
perience for medical practitioners, creating an environment 
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of problem-based learning and identifying current informa-
tion to support care decisions for individual patients.  Such 
an approach based on identifying the best evidence with 
which to answer a clinical question correlated with a criti-
cal appraisal of the existing evidence for validity and clini-
cal usefulness provides a foreground for effective evidence-
based interventions that are responsive to patient’s needs and 
priorities, avoiding uncritical acceptance of “usual practice”. 
The integration of EBM into clinical practice is a complex 
process and several steps have been developed to provide an 
efficient framework for medical practitioners. 
The First Step relates to converting the clinical informa-
tion into focused questions.  Thus, when a clinical problem 
arises during the care of a patient, it is very important to con-
struct a well-built clinical question that can address such key 
points as identifying the problem, considering standard and 
alternative management strategies as well as potential out-
comes.  A commonly used mnemonic in this regard is PICO: 
P = Patient or Problem (identifying the most important 
characteristics, similarities and particularities compared to 
other patients), I = Intervention (i.e. what are the options, 
risks and benefits, etc.), C = Comparison (i.e. comparing the 
existing alternatives for the chosen intervention), O = Out-
comes (i.e. what are we trying to reach with the chosen in-
terventions, possible complications and prognostic factors). 
The Second Step requires answering the focused ques-
tions based on “internal evidence”, which includes acquired 
knowledge through formal education and professional train-
ing, personal experience accumulated from daily practice, 
specific experience gained from this particular patient, etc.
[6].  Common questions that have to be answered during 
this step include, “How to proceed and what are the pros and 
cons based on the internal evidence?”, “How much the ex-
pertise in the field has evolved since the internal evidence 
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was created?”, “Are there any alternatives to reach this goal 
and is the internal evidence sufficient”? 
The Third Step extends the search from internal evidence 
to “external evidence”, which is represented by the available 
information from research studies performed on the topic of 
interest.  This is frequently accomplished by searching medi-
cal literature databases created for this purpose.  Selecting 
the appropriate resource and conducting a proper search 
represents an important step in the decision-making process 
and can be performed at several levels: formal, that involves 
searching the sources using formal terminology and key 
words; cognitive, that involves appraising the content; and 
analytical, when the practitioner understands the study de-
sign and potential implications on the presented data, be-
ing able to critically assess the available external resources. 
An important resource for external evidence can serve the 
Cochrane Library, which represents a collection of databases 
of systematic reviews and meta-analyses that summarize 
and interpret the results of medical research.  The Cochrane 
Library is supported by the Cochrane Collaboration and a 
number of other organizations, representing a key resource 
in evidence-based medicine worldwide.
The Fourth Step involves appraising the evidence for va-
lidity and applicability to clinical practice.  Examples of key 
issues requiring critical evaluation include randomization, 
blinding, concealed allocation, completed follow-up etc.  The 
common questions that have to be answered during this step 
are as follows: “Are the results of the study and the available 
evidence valid?” and “Will the results help for answering the 
questions related to this patient?”.  Commonly used mnemon-
ics in this step include DOE (Disease Oriented Evidence), 
POE (Patient Oriented Evidence) and POEM (Patient Ori-
ented Evidence that Matters) [7-11].  DOEs are very common 
in the medical literature, being frequently brought to our at-
tention by pharmaceutical representatives eager to promote 
their medication brands.  This kind of evidence needs to be 
approached with caution as it may be misleading and should 
not be used to change practice, especially when other types 
of evidence such as POEM are available [10].  POEs use pa-
tient-oriented outcomes, however, most such studies confirm 
what we already do and the findings don’t have the potential 
to change practice[11].  POEMs, on the other hand, use pa-
tient-oriented outcomes that have the potential to change our 
practice if the results are valid and applicable to our patient 
or clinical setting.  The concept of “patient-oriented evidence 
that matters” was developed by David Slawson and Allen 
Shaughnessy in 1994 [8].  Apart from being patient-oriented 
and having the potential to change practice, the POEM ap-
proach allows medical practitioners to focus only on what’s 
important for individual patients, significantly simplifying 
EBM.  Today, about 30 to 40 POEMs in the form of short 
synopses of research focusing on patient-oriented evidence 
that matters are published monthly in such clinical journals 
as American Family Physician, the British Medical Journal, 
the Journal of Family Practice, etc. [9].  This helps physicians 
to find useful information and assists them in caring for their 
patients during their clinical practice. 
The Fifth Step requires integrating “external evidence” 
that has been obtained through various resources into “in-
ternal evidence”.  As a whole, external and internal evidence 
may be mutually supportive, non-supportive, or even con-
flicting.  When two sources of information (external and 
internal) are non-supportive or conflicting, medical practi-
tioners may choose to use the external evidence to change 
their practice or to stick to their original opinion (i. e. to the 
“internal evidence”).  As a third option, a practitioner may 
also decide to discuss the conflict between the internal and 
external evidence with the patient, offering him/her the pos-
sibility to take part in the decision-making process.  Since 
by definition EBM integrates patient’s values with clinical 
expertise and current best research evidence, the patient’s 
preference is considered an essential part of EBM and, there-
fore, the last approach is recommended in this instance [6]. 
Because of this, some authors even call this stage as “return-
ing to patient”, when the acquired evidence is integrated with 
patient’s preferences and clinical expertise before being ap-
plied to practice.
The Sixth Step relates to evaluating the decision-making 
process and final results.  During this step the entire process 
is assessed, the outcome concerning the status of the patent 
is appreciated, the results are compared to those published 
in the literature as well as to the patient’s expectations and 
potential options for improvement are identified.  Further-
more, just because an intervention was effective in a rigor-
ously controlled trial, it still doesn’t mean it will show the 
same results in a clinical setting and potential negative con-
sequences should be also identified.  Familiarity with rele-
vant parameters and a proper interpretation of the obtained 
results become indispensible for a valid evaluation. 
The principles of EBM are not entirely new, as clini-
cians have always striven to combine their clinical expertise 
and their patients’ values with the best available evidence. 
However, interest in EBM has grown tremendously after the 
term “evidence-based medicine” was introduced in the early 
1990s and the subject was gradually included in the under-
graduate and postgraduate curriculum in many schools [12, 
13].  At the moment, the percentage of physicians who apply 
the EBM principles in their clinical practice remains largely 
unknown.  Despite enlisted advantages of EBM, the actual 
implementation depends on many factors like institutional 
culture, lack of knowledge about EBM and familiarity with 
the basic skills, barriers to practicing high-quality medicine, 
busy schedule and lack of time, the need to develop new 
skills, lack of information resources in the spoken language, 
shortage of coherent, consistent scientific evidence, impedi-
ment of clinical freedom, difficulties in applying evidence 
to the care of individual patients, etc. [13-19].  Studies per-
formed in Europe and Australia also indicate that textbooks 
are consulted more often than the Cochrane Library [17, 19, 
20].  A lot of efforts have been directed to overcome these 
limitations and encountered difficulties at various levels. As 
a result of these efforts and a wider availability of informa-
tion resources, EBM is gaining increasing support among 
the medical practitioners, facilitating their clinical activities 
in a variety of different ways such as:
78
Curierul medical, August 2015, Vol. 58, No 4
REvIEw ARTIClES
	Keeping abreast with updated medical literature and 
the growing body of developments in the field;
	Active communication with specialty consultants and 
other medical practitioners;
	Effective use of available medical literature and infor-
mation resources; 
	Targeted and effective data collection and information 
processing related to patient’s medical history, physical 
exam, laboratory and imaging findings;
	Optimized clinical decision-making and evidence-
based clinical management;  
	Helping clinicians to challenge dogma and to avoid un-
critical acceptance of “usual practice”;
	Teaching how to integrate the best available informa-
tion with patient’s values, clinical expertise and latest 
research evidence;
	Facilitating clinical judgment and allowing the physi-
cians to individualize the information for every pa-
tient’s situation;
	Stimulating a process of lifelong learning and an evi-
dence-based up-to-date clinical practice.
It should be noted that EBM always begins (step 1) and 
ends (steps 5 and 6) with the patient, being  usually triggered 
by a variety of patient’s encounters that generate questions 
about the etiology of his/her condition, utility of diagnostic 
tests, the effects of therapy, expected outcome and overall 
prognosis.  After identifying a problem, it is very important 
to formulate the question in such a way as to facilitate find-
ing an answer applicable to patient’s situation.  At the same 
time, it is equally important at this stage to determine the 
most appropriate type of study able to provide a valid answer 
to our question.  A brief summary of the main types of stud-
ies and study designs is provided by the so-called “evidence 
pyramid”.  The evidence pyramid also reflects the hierarchies 
of evidence that have been developed to help describe the 
quality of evidence that may be found to answer various 
questions.  When viewed from its base to top, the pyramid 
consists of several main components such as Animal Re-
search ®Case Reports ®Case Control Studies ®Cohort Studies 
®Randomized Control Trials ®Systematic Reviews ®Meta-Ana-
lysis.  Most information usually starts with an idea potential-
ly leading to laboratory research, development of diagnostic 
tools or therapeutic interventions, which are subsequently 
tested in laboratory models, animals, and finally in humans. 
Animal testing, or animal research, is the use of non-
human animals in experiments, commonly being conducted 
inside universities, medical schools or pharmaceutical com-
panies.  It represents an initial step in the research hierar-
chy; therefore the range and reliability of research results 
obtained in animals are invariably restricted for being ex-
tended to clinical practice.  Before a certain diagnostic tool 
or therapeutic agent can be authorized for use within general 
population, it should also undergo subsequent human test-
ing on a limited number of volunteers, followed by extended 
testing within several phases of clinical trials according to 
the established standards.
Case reports and Case series represent published reports 
about the clinical features, diagnosis or treatment of indi-
vidual patients.  Because they report single cases and use no 
control groups with which to compare the outcome, case re-
ports and case series have little statistical validity.  
Case control studies represent studies in which patients 
who already have a certain condition are compared with 
people who do not have that condition.  By definition, case-
control studies are always retrospective since they start with 
patients who already have the outcome, while the researcher 
is trying to link the outcome with prior exposures and po-
tential causative factors.  Case control studies require fewer 
resources, but are often less reliable than cohort studies and 
randomized controlled trials because revealing a statistical 
relationship does not necessarily show a cause-and-effect re-
lationship.
Cohort studies take a group of people who share a com-
mon characteristic or experience within a certain period 
(e. g., taking a particular treatment or have an exposure), fol-
low them over time, and then compare the outcomes with 
a similar group that has not been affected by the treatment 
or exposed factor.  Of note is that Case control studies and 
Cohort studies represent Observational Studies, where the re-
searchers observe the effect of a risk factor, diagnostic test or 
treatment without trying to influence what happens.  Obser-
vational studies are inherently not as reliable as experimental 
studies, since the studied groups may differ in ways other 
than in the variable under study.  Sometimes, however, they 
may represent the only way to explore certain questions.  For 
example, it would be unethical to design an experimental 
study to deliberately expose patients to certain harmful risk 
factors. Randomized controlled trials (RCTs) are carefully 
planned projects in which subjects are randomly assigned 
to two or more groups.  One group receives the intervention 
(a certain drug or intervention) while the control group re-
ceives no intervention or placebo.  This allows a formal com-
parison between intervention groups and control groups 
(no intervention), differences in the outcomes being directly 
linked to the intervention.  Additional strengths include ran-
domization and blinding that reduce the potential for bias. 
As a study design a randomized controlled trial represents 
an experiment and can provide scientific evidence related to 
the cause and effect.  If the subjects are not randomly as-
signed to the treatment or control groups (i.e. the subject is 
allowed to choose which group to join or the investigator 
is assigning to a particular group for any other reason), the 
study is then called Controlled Clinical Trial (CCT) instead 
of Randomized Controlled Trial.  Both RCTs and CCTs rep-
resent Experimental Studies, however, CCTs have a higher 
chance for “bias” compared to RCTs, since non-randomly 
assigned subjects have the potential to influence the fi-
nal results.  The RCTs are commonly considered the “gold 
standard” for producing reliable evidence because little is 
left to chance, even though such studies are usually time-
consuming and expensive.  A systematic review (also called 
systematic literature review or structured literature review) 
is a literature review focused on a research question that in-
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volves a systematic search with a view to minimizing bias, 
followed by a formal appraisal and synthesis so that relevant 
conclusions can be drawn and decisions be made.  The main 
difference from a traditional narrative review is that a nar-
rative review is mainly descriptive and does not involve a 
systematic search of the literature for minimizing bias, while 
a  systematic review typically involves a detailed plan and a 
search strategy derived as a priority, with the goal of reduc-
ing bias by identifying, appraising, and synthesizing all rel-
evant studies on a particular topic [21, 22].  A systematic re-
view may also include a quantitative statistical analysis of the 
collected data, called a meta-analysis.  Thus, a meta-analysis 
will examine and select a number of valid studies on a topic 
and combine the results using formal statistical calculations. 
Many systematic reviews contain meta-analyses, but not all 
of them [22].  A well-known and respected international 
organization that promotes, supports, and disseminates sys-
tematic reviews and meta-analyses in the field of medicine is 
the Cochrane Collaboration (www.cochrane.org). 
Familiarity with the hierarchy of study designs allows a 
practitioner to keep in mind the “evidence pyramid” when 
searching for the best evidence.  However, the highest level 
of study to answer a particular question may not always be 
found or available. In such situation, a practitioner may con-
sider moving down the pyramid.  Furthermore, the highest 
ranked level of evidence might not always be applicable to 
a particular question.  For example, although randomized 
clinical trials are considered the “gold standard” for estab-
lishing the effects of a treatment of intervention, they might 
not represent the best sources for answering questions about 
diagnosis, prognosis or harm [13].  Hence, familiarity with 
the types of study designs and their applicability to different 
clinical situations becomes indispensible when evaluating 
the evidence.  Last, but not least, it should be also remem-
bered that evidence, by itself, does not make a decision for a 
clinical practitioner, even though it represents an important 
variable in the process of EBM practicing.  Therefore, the last 
two steps of EBM relate to integrating internal and external 
evidence with patient’s preferences and clinical expertise be-
fore being applied to practice followed by a subsequent as-
sessment of the decision-making process and final results. 
The integration of these EBM steps enables both the practi-
tioner and patient to optimize their clinical decisions, so that 
optimal clinical outcomes can be achieved.
Conclusions
1. EBM integrates the best available information with 
patient’s values, clinical expertise and latest research evidence.
2. A significant progress in the practical implementation 
of EBM has been made by the increasing availability of EBM 
resources able to search, appraise and summarize the literature 
on a given topic. 
3. An important element of external evidence and EBM 
is represented by the systematic reviews and meta-analyses, 
designed to provide relevant summaries about the best avai-
lable evidence on a specific topic while minimizing the bias.
4. As a result of increasing demands for an evidence-based 
approach and a wider availability of information resources, 
EBM is gaining increasing support among the medical practi-
tioners, optimizing their clinical decision-making, increasing 
their confidence and facilitating their clinical practice. 
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